Monday Sep 04, 2023

Low Grade Ovarian Cancer: The Expert Consensus,’ with Drs. Rachel Grisham, David Gershenson, and Brian Slomovitz

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rachel Grisham, David Gershenson, and Brian Slomovitz to discuss "Low Grade Ovarian Cancer: The Expert Consensus".  

Highlights:  

  • A panel of experts convened in October 2022 to discuss recent scientific and clinical progress, resulting in a consensus document that provides recommendations for diagnosis, treatment, and ongoing research to improve patient care of low-grade serous ovarian cancer. 
  • Alterations affecting the MAPK pathway are frequent in low-grade serous ovarian cancer and provide prognostic information. 
  • Recent advances in the use of targeted therapy (in particular with novel MEK inhibitor and endocrine therapy regimens) have led to unprecedented response rates in patients with recurrent low-grade serous ovarian cancer.

Copyright 2023 All rights reserved.

Version: 20240731